One shot to stop Group B Streptococcus
This fact sheet describes PATH’s work to develop a vaccine against Group B Streptococcus. It details current prevention methods, global disease burden, and the maternal immunization strategy. It also describes PATH’s vaccine development partnership with the Biovac Institute in Cape Town, South Africa.
Publication date: August 2018